Stratec SE (ETR:SBS)

Market Cap	241.17M -16.1%
Revenue (ttm)	260.25M +1.8%
Net Income	15.36M +21.8%
EPS	1.26 +22.7%
Shares Out	12.16M
PE Ratio	15.70
Forward PE	14.80
Dividend	0.60 (3.02%)
Ex-Dividend Date	Jun 30, 2025

Volume	9,445
Average Volume	10,576
Open	18.50
Previous Close	18.48
Day's Range	18.50 - 19.94
52-Week Range	16.36 - 33.10
Beta	0.80
RSI	60.07
Earnings Date	Apr 28, 2026

About Stratec SE

Stratec SE, together with its subsidiaries, provides automation solutions for in-vitro diagnostics and life science companies in Germany, the European Union, and internationally. The company designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers. It also provides consumables for diagnostics and medical applications; and integrating instrumentation and software. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1979
• Employees: 1,420
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: SBS

Financial Performance

In 2024, Stratec SE's revenue was 257.62 million, a decrease of -4.73% compared to the previous year's 270.41 million. Earnings were 16.02 million, an increase of 4.24%.